logo
Share SHARE
FONT-SIZE Plus   Neg

Salix, Progenics Announce FDA Extension Of RELISTOR SNDA Goal Date To July 27

Salix Pharmaceuticals, Ltd. (SLXP) and Progenics Pharmaceuticals (PGNX) announced that the Food and Drug Administration, or FDA, has extended the Prescription Drug User Fee Act goal date for the Agency's review of the Supplemental New Drug Application, or sNDA, for RELISTOR (methylnaltrexone bromide) injection for subcutaneous use for the treatment of opioid-induced constipation in adult patients with chronic, non-cancer pain.

The FDA has notified Salix that it requires additional time for a full review of the submission and has extended the April 27, 2012 goal date by the standard extension period of three months. The extended user fee goal date is July 27, 2012. The extension requested no additional studies.

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Fox News' two black employees sued Judith Slater, the company's longtime comptroller, for alleged racial harassment, and the cable news network for ignoring their claims of discrimination. They are reportedly seeking unspecified damages. Samsung Electronics Co. Ltd. launched Galaxy S8 flagship smartphones, its first new smartphone since the withdrawal of Galaxy Note 7. The Samsung Galaxy S8 and S8 Plus smartphones will go on sale on April 21. At a media event in New York on Wednesday, the company launched the two versions of the Galaxy S8, code-named Dream internally, with 6.2-inch and 5.8-inch curved screens. Consumers in Nigeria are calling for a boycott of Coca-Cola products sold in the African nation after a high court judge ruled that the products could be "poisonous". Justice Adedayo Oyebanji of the Lagos High Court ruled that high levels of benzoic acid and sunset additives in Coca-Cola's soft drinks could pose a health risk to consumers when mixed with ascorbic acid, commonly known as Vitamin C.
comments powered by Disqus
Follow RTT